3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Prostatic Neoplasms
3
Melanoma
2
Disease
2
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Esophageal Neoplasms
1
Desmoid Tumors
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Adenocarcinoma
1
Interventions
Bevacizumab
35
durvalumab
23
atezolizumab
22
Nivolumab
20
lenvatinib
19
tremelimumab
16
Specimen Handling
14
Magnetic Resonance Spectroscopy
12
sintilimab
11
pembrolizumab
9
Ipilimumab
9
tislelizumab
7
Sorafenib
7
cabozantinib
5
X-Rays
5
Immunoglobulin G
5
Disulfides
5
Cyclophosphamide
5
regorafenib
4
Radiotherapy
4
Radiosurgery
4
Radiation
4
Oxaliplatin
4
Immunotherapy
4
Ethiodized Oil
4
fludarabine
3
donafenib
3
Surgical Procedures, Operative
3
Folfox protocol
3
Fluorouracil
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Cryosurgery
×
90 days
×
Clear all
No trials found.